Related articles

The answer lies in the unique biological profile of each patient’s tumour — RGCC Onconomics Plus® can read it with precision

The same non-small-cell lung cancer: why do some patients remain stable on osimertinib for over a year while others develop resistance within months?
Triple-negative breast cancer: why do some complete standard chemotherapy with tolerable side effects while others require dose reductions due to severe myelosuppression?
Metastatic colorectal cancer: why do certain individuals achieve long-term disease control when specific natural compounds are added, while others see no benefit?

And the gentlest way to open them again

Lymphoma-related fatigue is never just “lack of calories”.
It is actually three invisible pathways blocked at the same time:

● Oxygen can’t reach the cells
● Mitochondria run out of power
● Microcirculation turns into mud

When these three drains are cleared, energy returns like turning on a tap — naturally and steadily.

and the Vital Role of Albumin Infusion in Supportive Care
In pancreatic cancer, chronic pancreatitis, or after pancreatic surgery, loss of exocrine function almost always leads to the dreaded duo of steatorrhea + severe protein-calorie malnutrition. The classic picture is unmistakable:
• Greasy, floating, foul-smelling stools
• Rapid weight loss (5–10 kg or more in a single month)
• Pitting edema in the legs, face, and sometimes the whole body

When the liver is under strain (liver cancer, cirrhosis, chronic hepatitis B/C, fatty liver, or heavy chemotherapy), it becomes “sensitive and tired.” The golden rule for supplementation is simple: Choose only what is easiest for the liver to handle and truly needed right now.

In colorectal cancer, prolonged diarrhea, surgery, poor appetite, and tumor consumption almost always lead to hypoalbuminemia (serum albumin < 3.5 g/dL, often dropping to 2.5–2.8 g/dL in severe cases). Albumin is far more than just a “nutrition marker”—it is the body’s core transport protein. When it stays low for weeks or months, a vicious cycle begins: edema, delayed wound healing, immune collapse, ascites, and even forced treatment breaks.

Nourishing the body while fighting cancer
From diagnosis through treatment and recovery, nearly every colorectal cancer patient experiences some degree of nutrient depletion. Surgery shortens the intestine, chemotherapy suppresses appetite, targeted/immunotherapies trigger diarrhea, and radiation irritates the mucosa. These factors quietly drain protein, vitamins, and minerals. If not replenished thoughtfully and precisely, patients face worsening fatigue, weakened immunity, poor wound healing, and even treatment interruptions.

In the past, many cancer-related care plans were based on a “standard process,” as if every patient should follow the same pathway for care, recovery, and adjustment. However, with the advancement of research, we now understand that cancer is not a single disease, but a complex condition involving different genetic compositions, biological characteristics, and personal life backgrounds.
Therefore, “personalization” is no longer a term exclusive to advanced medical science—it is a basic care concept that every patient deserves.

Personalized cancer care emphasizes that:
Every body is different, every cancer behaves differently, and therefore, care strategies should also be different.

Fatigue is one of the most common and distressing symptoms experienced by cancer patients. Unlike ordinary tiredness, cancer-related fatigue is persistent, not relieved by rest, and can affect both physical and mental well-being.
This exhaustion is often the result of complex metabolic, inflammatory, and nutritional changes that occur during cancer and its treatments. Understanding why it happens — and how human albumin helps — is key to better recovery and energy restoration.